We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$191M
2
SMAR
Smartsheet Inc.
SMAR
+$188M
3
FYBR
Frontier Communications
FYBR
+$124M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$234M
2
MRO
Marathon Oil Corporation
MRO
+$222M
3
SRCL
Stericycle Inc
SRCL
+$172M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPKL
251
Spark I Acquisition Corp
SPKL
$101M
$711K 0.02%
66,832
– –
CNTB
252
Connect Biopharma Holdings
CNTB
$138M
$705K 0.02%
510,701
– –
CGEM icon
253
Cullinan Oncology
CGEM
$1.12B
$683K 0.02%
56,095
+10,120
+22% +$145K
SLRN
254
DELISTED
ACELYRIN
SLRN
$665K 0.02%
211,938
+48,214
+29% +$233K
ABNB icon
255
Airbnb
ABNB
$104B
$657K 0.02%
+5,000
New +$673K
DAWN
256
DELISTED
Day One Biopharmaceuticals
DAWN
$634K 0.02%
+50,020
New +$696K
ACRV icon
257
Acrivon Therapeutics
ACRV
$74.9M
$619K 0.02%
102,784
+23,535
+30% +$171K
MRUS
258
DELISTED
Merus
MRUS
$611K 0.02%
14,540
+4,618
+47% +$222K
PRQR icon
259
ProQR Therapeutics
PRQR
$268M
$602K 0.02%
+227,020
New +$721K
MRSN
260
DELISTED
Mersana Therapeutics
MRSN
$586K 0.01%
16,401
-6,400
-28% -$331K
ADSK icon
261
Autodesk
ADSK
$52.6B
$586K 0.01%
1,983
-3,017
-60% -$891K
ERAS icon
262
Erasca
ERAS
$6.23B
$576K 0.01%
229,600
+159,600
+228% +$438K
NARI
263
DELISTED
Inari Medical, Inc. Common Stock
NARI
$567K 0.01%
11,102
-3,998
-26% -$197K
XRX icon
264
PUT
Xerox
XRX
$425M
$561K 0.01%
278,300
– –
INZY
265
DELISTED
Inozyme Pharma
INZY
$557K 0.01%
201,232
-25,000
-11% -$95.1K
VSAT icon
266
PUT
Viasat
VSAT
$11.2B
$553K 0.01%
73,300
– –
STRO icon
267
Sutro Biopharma
STRO
$413M
$553K 0.01%
30,062
-3,760
-11% -$115K
THRD
268
DELISTED
Third Harmonic Bio
THRD
$553K 0.01%
53,740
+1,446
+3% +$18K
MRVL icon
269
Marvell Technology
MRVL
$195B
$552K 0.01%
5,000
-5,000
-50% -$464K
VTYX
270
DELISTED
Ventyx Biosciences
VTYX
$534K 0.01%
244,000
+44,000
+22% +$99.7K
GPCR icon
271
Structure Therapeutics
GPCR
$3.64B
$529K 0.01%
19,520
+1,520
+8% +$53.9K
TM icon
272
Toyota
TM
$225B
$525K 0.01%
+2,700
New +$475K
MGM icon
273
PUT
MGM Resorts International
MGM
$11.2B
$524K 0.01%
125,000
– –
ASAN icon
274
Asana
ASAN
$2.1B
$507K 0.01%
25,000
– –
HLF icon
275
PUT
Herbalife
HLF
$1.25B
$499K 0.01%
82,400
– –
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.